← Evidence map

ArticleScience progress

Implications for cystic fibrosis therapy: Potentiator icenticaftor is superior to ivacaftor in improving function and maintaining stability of F508del CFTR.

Deborah M Cholon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
cites it
Full record →Abstract, authors, funding and every citing paper · PMID 41055920